Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033

Tuberculosis Diagnostics Market 2024 – By Type (Full Size, Microdots, Mini Reflex.), By Platform (Ground-Based, Air-Based, Sea-Based), By Application (Hunting, Armed Forces, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 $3500.00 | Pages : 353 | Published : October 2024 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Tuberculosis Diagnostics Market Definition

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

TB is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

The tuberculosis diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of tuberculosis diagnostics tests that are used for detection of TB.

Book your 30 minutes free consultation with our research experts

Contact Us

Tuberculosis Diagnostics Market Size

The global tuberculosis diagnostics market reached a value of nearly $2,056.8 million in 2023, having grown at a compound annual growth rate (CAGR) of 3.3% since 2018. The market is expected to grow from $2,056.8 million in 2023 to $2,702.0 million in 2028 at a rate of 5.6%. The market is then expected to grow at a CAGR of 5.9% from 2028 and reach $3,596.3 million in 2033.  

Growth in the historic period resulted from the rise in the adoption of nucleic acid testing, increasing research and development investments, emergence of drug-resistant TB and strong government support. Factors that negatively affected growth in the historic period include low healthcare access in developing countries and stigma and discrimination associated with tuberculosis.

Going forward, the increasing global initiatives to end TB, increasing aging populations, high prevalence of tuberculosis, increasing regulatory approvals for tuberculosis diagnostics, rising healthcare expenditure globally and expanding healthcare infrastructure will drive the market. Factors that could hinder the growth of the tuberculosis diagnostics market in the future include lack of trained healthcare professionals and high cost of diagnostic and testing infrastructure.  

Tuberculosis Diagnostics Market Drivers

The key drivers of the tuberculosis diagnostics market include:

Increasing Global Initiatives To End TB

Increasing global initiatives to end TB are expected to propel the growth of the tuberculosis diagnostics market in the forecast period. Global initiatives drive investment in TB research and diagnostic technology by providing substantial funding and resources. This financial support accelerates the development of advanced diagnostic tools, such as rapid and molecular tests, essential for early TB detection. Awareness campaigns and widespread screening programs further increase demand for these solutions, while collaborative efforts enhance the implementation and expansion of innovative diagnostic technologies. For example, the WHO (World Health Organization)’s End TB strategy aims to end the global TB epidemic by 2035.  In March 2024, the WHO celebrated World Tuberculosis (TB) Day with the theme “Yes! We can end TB." World TB Day serves as a platform to reaffirm commitment and drive action towards ending TB. WHO/Europe advocates for increased investment, adoption of the latest WHO recommendations, and embracing innovations. The organization also emphasizes the involvement of civil society organizations to advance TB control efforts.  Additionally, in July 2022, The Stop TB Partnership, a Switzerland-based international, nongovernmental organization working to eliminate tuberculosis as a public health problem, launched the Global Plan to End TB 2023–2030, detailing the key actions and financial resources required to eliminate tuberculosis, the world's second-leading infectious disease killer after COVID-19, by 2030.  This cost-effective plan outlines the strategic priorities and necessary investments to eradicate TB as a global health threat. Therefore, the increasing global initiatives to end TB will drive the tuberculosis diagnostics market.

Tuberculosis Diagnostics Market Restraints

The key restraints on the tuberculosis diagnostics market include:

Lack Of Trained Healthcare Professionals

The lack of trained healthcare professionals is expected to restrict the growth of the tuberculosis diagnostics market. A shortage of trained healthcare professionals limits the effective use and implementation of advanced tuberculosis (TB) diagnostic tools. Without adequate expertise, diagnostic procedures may be performed inaccurately or inefficiently, reducing the overall effectiveness of TB detection and management. This skill gap can hinder the adoption of new diagnostic technologies and impede efforts to expand screening and treatment programs. For instance, in January 2023, according to the Global Strategy on Human Resources for Health: Workforce 2030 published by the World Health Organization (WHO), there is an anticipated shortfall of 10 million healthcare workers globally by 2030 from 65 million in 2020, mainly in low- and middle-income nations.  Additionally, in January 2023, according to the American Hospital Association (AHA), a US-based national organization representing hospitals and health care networks, there will be a shortage of up to 124,000 physicians by 2033, along with a demand for at least 200,000 nurses annually to meet increasing needs. Further, a study anticipates that, based on current workforce trends, over 6.5 million healthcare professionals will exit their roles by 2026, with only 1.9 million replacements anticipated, resulting in a national shortage exceeding 4 million workers.  Therefore, a lack of trained healthcare professionals will restrict the growth of the tuberculosis diagnostics market.

Tuberculosis Diagnostics Market Trends

Major trends shaping the tuberculosis diagnostics market include:

Next Generation Sequencing (NGS) Platforms For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in April 2024, QIAGEN, a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world’s leading infectious disease killer. The QIAseq xHYB Mycobacterium tuberculosis Panel represents a major advancement in solving the problem of bacterial WGS from complex host samples, using next-generation sequencing (NGS).  Further, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company, introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

New Product Innovations For Advanced Diagnostics Solutions

Product innovations are a key trend in the tuberculosis diagnostics market, as companies look to stay competitive and meet the evolving needs and preferences of consumers. Companies in the tuberculosis diagnostics market are focusing on product innovations and developing new product solutions to strengthen their position in the market. For example, in April 2024, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an Indian medical institution, developed a diagnostic kit to detect pulmonary tuberculosis at an early stage. AG Chitra TB diagnostic kit had been approved by the Central Drugs Standard Control Organization (CDSCO) for manufacturing and marketing. The newly developed AG Chitra TB diagnostic kit has an accuracy of 97.71%. The technology has been developed as an open platform, avoiding the need for proprietary machines to amplify DNA.  Further, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, launched the BD MAX MDR TB (Tuberculosis) test, a diagnostic test to enable clinicians to rapidly test for tuberculosis and multidrug resistance as a first- line test, which is performed on BD MAX molecular diagnostic system. Clinicians use the test to simultaneously detect bacteria that cause TB and determine if the bacteria contain mutations associated with resistance to two important first-line drugs, Isoniazid (INH) and Rifampicin (RIF).

Opportunities And Recommendations In The Tuberculosis Diagnostics Market

Opportunities – The top opportunities in the tuberculosis diagnostics market segmented by test type will arise in the smear microscopy segment, which will gain $161.9 million of global annual sales by 2028. The top opportunities in the tuberculosis diagnostics market segmented by disease stage will arise in the active tuberculosis segment, which will gain $443.7 million of global annual sales by 2028. The top opportunities in the tuberculosis diagnostics market segmented by end-user will arise in the hospitals and diagnostic laboratories segment, which will gain $272.2 million of global annual sales by 2028. The tuberculosis diagnostics market size will gain the most in the USA at $188.3 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the tuberculosis diagnostics companies to focus on next-generation sequencing for tuberculosis diagnostics, focus on product innovations in tuberculosis diagnostics, focus on T cell-based diagnostics for tuberculosis, focus on artificial intelligence in tuberculosis diagnostics, focus on portable TB diagnostic tools, focus on technological advancements in TB diagnostics, focus on blood-based tests in tuberculosis diagnostics, focus on the nucleic acid testing segment, focus on the latent tuberculosis segment, expand in emerging markets, continue to focus on developed markets, focus on collaborations with governments for TB diagnostics access, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions and focus on the physician’s office laboratories segment.

Tuberculosis Diagnostics Market Segmentation

The tuberculosis diagnostics market is segmented by test type, by disease stage and by end-user.

By Test Type –
The tuberculosis diagnostics market is segmented by test type into:
    • a) Radiographic Tests
    • b) Nucleic Acid Testing
    • c) Cytokine Detection Tests
    • d) Drug Resistance Tests
    • e) Skin Test / Mantoux Test (TST)
    • f) Blood/Serology Test
    • g) Smear Microscopy Tests
    • h) Cell Culture-Based Tests
    • i) Other Test Types
The smear microscopy tests market was the largest segment of the tuberculosis diagnostics market segmented by test type, accounting for 25.0% or $513.8 million of the total in 2023. Going forward, the nucleic acid testing segment is expected to be the fastest growing segment in the tuberculosis diagnostics market segmented by test type, at a CAGR of 6.0% during 2023-2028.

By Disease Stage –
The tuberculosis diagnostics market is segmented by disease stage into:
    • a) Latent Tuberculosis
    • b) Active Tuberculosis
The active tuberculosis market was the largest segment of the tuberculosis diagnostics market segmented by disease stage, accounting for 71.0% or $1,461.0 million of the total in 2023. Going forward, the latent tuberculosis segment is expected to be the fastest growing segment in the tuberculosis diagnostics market segmented by disease stage, at a CAGR of 6.0% during 2023-2028.

By End User –
The tuberculosis diagnostics market is segmented by end user into:
    • a) Hospitals And Diagnostic Laboratories
    • b) Physician’s Office Laboratories
    • c) Reference Laboratories
    • c) Academics And Research Facilities
The hospitals and diagnostic laboratories market was the largest segment of the tuberculosis diagnostics market segmented by end-user, accounting for 41.9% or $861.2 million of the total in 2023. Going forward, the physician’s office laboratories segment is expected to be the fastest growing segment in the tuberculosis diagnostics market segmented by end-user, at a CAGR of 5.8% during 2023-2028.

By Geography - The tuberculosis diagnostics market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
Asia-Pacific was the largest region in the tuberculosis diagnostics market, accounting for 40.3% or $828.5 million of the total in 2023. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the tuberculosis diagnostics market will be Asia-Pacific and North America, where growth will be at CAGRs of 6.9% and 5.5% respectively. These will be followed by Western Europe and Eastern Europe, where the markets are expected to grow at CAGRs of 4.1% and 4.0% respectively.

Tuberculosis Diagnostics Market Competitive Landscape

Major Competitors are:

  • Beckton, Dickinson and Company
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • bioMérieux SA
  • Danaher Corporation (Cepheid, Inc.)

    • Other Competitors Include:

  • Abbott Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation
  • SRL Diagnostics
  • Apollo Hospitals
  • Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST)
  • Molbio Diagnostics Pvt. Ltd.
  • Oxford Vacmedix (OVM)
  • Roche Diagnostics India Pvt Ltd.
  • Biocartis
  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • EMPE Diagnostics
  • Siemens AG
  • Fresenius
  • Koninklijke Philips
  • Novartis
  • LumiraDx Limited
  • TestLine Clinical Diagnostics s.r.o.
  • Hologic
  • Bayer AG
  • Cantel Medical Corporation
  • Meridian Bioscience
  • LabCorp
  • Quest Diagnostics
  • T2 Biosystems
  • Sanofi
  • Sierra Molecular Inc.
  • Medicago Inc.
  • AdvaCare Pharma
  • Akonni Biosystems Inc.
  • Par Pharmaceutical
  • Lionex GmbH
  • Creative Diagnostics
  • Epistem Limited
  • Gen-Probe
  • M42
  • Revvity Inc.
  • Médecins Sans Frontières (MSF)
  • Mylab Discovery Solutions
  • Quotient Limited

      • Table Of Contents

      1Executive Summary

      1.1 Tuberculosis Diagnostics – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Tuberculosis Diagnostics Market Definition And Segmentations

      6.4 Market Segmentation By Test Type

      6.4.1 Radiographic Test

      6.4.2 Nucleic Acid Testing

      6.4.3 Cytokine Detection Test

      6.4.4 Drug Resistance Test

      6.4.5 Skin Test/Mantoux Test (TST)

      6.4.6 Blood Test/Serology Test

      6.4.7 Smear Microscopy

      6.4.8 Cultured-Based Tests

      6.4.9 Other Test Types

      6.5 Market Segmentation By Disease Stage

      6.5.1 Latent Tuberculosis

      6.5.2 Active Tuberculosis

      6.6 Market Segmentation By End-User

      6.6.1 Hospitals And Diagnostic Laboratories

      6.6.2 Physician’s Office Laboratories

      6.6.3 Reference Laboratories

      6.6.4 Academics And Research Facilities

      7 Major Market Trends

      7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics

      7.2 New Product Innovations For Advanced Diagnostics Solutions

      7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability

      7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy

      7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings

      7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics

      7.7 Technology Advancements To Transform The Landscape Of TB Detection

      7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB

      8 Tuberculosis Diagnostics Market – Macro-Economic Scenario

      8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market

      8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market

      8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Tuberculosis Diagnostics Market Segmentation

      10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Tuberculosis Diagnostics Market, Regional and Country Analysis

      11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis

      13.6 UK Market

      13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Tuberculosis Diagnostics Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Tuberculosis Diagnostics Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Becton, Dickinson and Company

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Qiagen N.V.

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 F. Hoffman-La Roche Ltd

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 BioMerieux SA

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      19.6 Danaher Corporation (Cepheid, Inc.)

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      20 Tuberculosis Diagnostics Market Other Major And Innovative Companies

      20.1 Abbott Laboratories, Inc

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Bio-Rad Laboratories, Inc

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 Thermo Fisher Scientific, Inc

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 PerkinElmer, Inc

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Bio-Techne Corporation

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 Hologic, Inc

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 Laboratory Corporation

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Siemens Healthineers

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Akonni Biosystems Inc

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Hain Lifescience GmbH

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 Creative Diagnostics

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 Lionex GmbH

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 Genedrive PLC

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 Mylab Discovery Solutions Pvt. Ltd

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 AdvaCare Pharma

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Molbio Diagnostics Acquired Prognosys Medical Systems

      23.2 SD Biosensor Acquired Relab

      23.3 Hologic Inc. Acquired Mobidiag Oy

      23.4 PerkinElmer Acquired Oxford Immunotec

      23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

      24 Opportunities And Strategies

      24.1 Global Tuberculosis Diagnostics Market In 2028 – Countries Offering Most New Opportunities

      24.2 Global Tuberculosis Diagnostics Market In 2028 – Segments Offering Most New Opportunities

      24.3 Global Tuberculosis Diagnostics Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Tuberculosis Diagnostics Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Tuberculosis Diagnostics Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Tuberculosis Diagnostics Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 9:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 10: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 11: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: China GDP Per Capita, 2018-2023, $
    • Table 14:  China Population, 2018-2028, Millions
    • Table 15: China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 16: China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 34:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 35: Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 36: Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $Million
    • Table 54:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 55: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 56: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 62:  North America Population, By Country, 2018-2028, Millions
    • Table 63: North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 64: North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: USA GDP Per Capita, 2018-2023, $
    • Table 67:  USA Population, 2018-2028, Millions
    • Table 68: USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 69: USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $Million
    • Table 75:  South America Population, By Country, 2018-2028, $Million
    • Table 76: South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 77: South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 83:  Middle East Population, By Country, 2018-2028, Millions
    • Table 84: Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 85: Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 88:  Africa Population, By Country, 2018-2028, Millions
    • Table 89: Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 90: Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Becton Dickinson and Company (BD) – Financial Overview, 2019 – 2023, $Billion
    • Table 93: Qiagen N.V. – Financial Overview, 2019 – 2023, $Billion
    • Table 94: F. Hoffmann-La Roche Ltd – Financial Overview, 2019 – 2023, $Billion
    • Table 95: BioMerieux SA – Financial Overview, 2019 – 2023, $Billion
    • Table 96: Danaher Corporation – Financial Overview, 2019 – 2023, $Billion
    • Table 97: Tuberculosis Diagnostics Market, Competitive Benchmarking (In USD Millions)
    • Table 98: Tuberculosis Diagnostics Market, Competitive Dashboard
    • Table 99: Global Tuberculosis Diagnostics Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 100: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By Test Type, 2023 – 2028
    • Table 101: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By Disease Stage, 2023 – 2028
    • Table 102: Global Tuberculosis Diagnostics Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028
    • Table 103: Tuberculosis Diagnostics Market Data Sources

    List Of Figures

      Figure 1: Global Tuberculosis Diagnostics Market Segmentation By Test Type
    • Figure 2: Global Tuberculosis Diagnostics Market Segmentation By Disease Stage
    • Figure 3: Global Tuberculosis Diagnostics Market Segmentation By End-User
    • Figure 4: Global Tuberculosis Diagnostics Market, Historic, 2018 – 2023, $ Million
    • Figure 5: Global Tuberculosis Diagnostics Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 6: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 7: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Becton Dickinson and Company (BD) – Financial Overview, 2019 – 2023, $ Billion
    • Figure 78: Qiagen N.V. – Financial Overview, 2019 – 2023, $ Billion
    • Figure 79: F. Hoffmann-La Roche Ltd – Financial Overview, 2019 – 2023, $ Billion
    • Figure 80: BioMerieux SA – Financial Overview, 2019 – 2023, $ Billion
    • Figure 81: Danaher Corporation – Financial Overview, 2019 – 2023, $ Billion
    • Figure 82: Geographic Regions Covered

    Global Orthopedic Devices Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Nephrology And Urology Devices Market Overview In 2022?

    Read More

    How Will The Medical Aesthetics Market Grow In 2022?

    Read More

    Global Dental Diagnostic Imaging Devices And Equipment Market 2022 – Market Opportunities And Strategies

    Read More

    The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the temperature monitoring devices market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the urinary incontinence and pelvic organ prolapse devices and equipment market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the dental equipment and supplies market research report 2022 with industry size, share, segments and market growth

    Read More

    Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare Settings), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Radiotherapy Devices Global Market Report 2024 – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications), By End Users (Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Tumor Ablation Therapy Devices Global Market Report 2024 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Laparoscopic, Percutaneous), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Hospitals, Oncology Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Devices Global Market Report 2024 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Tumor Embolization Devices Global Market Report 2024 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Liposomal Drug Delivery Devices Global Market Report 2024 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Gastrointestinal Devices Global Market Report 2024 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2024-2033

    View Report